Two Robotic Lung Surgery Methods Compared for Lung Cancer Tumor Removal
Compares two robotic surgery methods for removing lung tumors in adults with lung cancer.
Plain-language title generated from the registry record
Registry title: Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLC
Key facts
- Where
- L'Hospitalet de Llobregat, SpainSee the site
Where in Spain
- Hospital Universitari de BellvitgeL'Hospitalet de Llobregat, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Carlos Déniz
- Trial code
- NCT07818135
- Record updated
- 14 September 2026
- Original description
This study compares two established robotic surgical approaches for removing lung tumors in adults with non-small cell lung cancer: biportal robotic-assisted thoracic surgery (biRATS) and multiportal robotic-assisted thoracic surgery (multiRATS). Participants are assigned at random to one of the two approaches. The study will compare surgical safety, recovery after surgery, pain, length of hospital stay, quality of life, and other clinical outcomes during 12 months of follow-up.Read full original descriptionShow less
Clinical Trial in Patients With Non-Small Cell Lung Cancer Undergoing Biportal Versus Multiportal Robotic Thoracic Surgery: Comparison of Two Innovative Techniques
This study compares two established robotic surgical approaches for removing lung tumors in adults with non-small cell lung cancer: biportal robotic-assisted thoracic surgery (biRATS) and multiportal robotic-assisted thoracic surgery (multiRATS). Participants are assigned at random to one of the two approaches. The study will compare surgical safety, recovery after surgery, pain, length of hospital stay, quality of life, and other clinical outcomes during 12 months of follow-up.
Inclusion: Adults aged 18 years or older, of any sex; Non-small cell lung cancer considered clinically resectable, confirmed preoperatively or during surgery; Candidate for pulmonary resection by robotic thoracic surgery; Written informed consent.
Exclusion: Thoracic anatomical abnormalities that preclude or materially affect robotic surgery; Surgery not performed by a participating surgeon with comparable experience in biRATS and multiRATS; Active thoracic infection; Declines participation or cannot provide written informed consent.